Austar Lifesciences Limited (6118.HK)

HKD 0.79

(0.0%)

Operating Expenses Summary of Austar Lifesciences Limited

Austar Lifesciences Limited's latest annual operating expenses in 2023 was 366.04 Million CNY , down -6.29% from previous year.
Austar Lifesciences Limited's latest quarterly operating expenses in 2024 Q2 was 128.16 Million CNY , down 0.0% from previous quarter.
Austar Lifesciences Limited reported a annual operating expenses of 368.21 Million CNY in annual operating expenses 2022, up 134.75% from previous year.
Austar Lifesciences Limited reported a annual operating expenses of 156.85 Million CNY in annual operating expenses 2021, down -44.45% from previous year.
Austar Lifesciences Limited reported a quarterly operating expenses of 345.06 Million CNY for 2023 FY, down -6.29% from previous quarter.
Austar Lifesciences Limited reported a quarterly operating expenses of 192.44 Million CNY for 2023 Q2, up 4.98% from previous quarter.

Annual Operating Expenses Chart of Austar Lifesciences Limited (2023 - 2013)

Historical Annual Operating Expenses of Austar Lifesciences Limited (2023 - 2013)

Year	Operating Expenses	Operating Expenses Growth
2023	366.04 Million CNY	-6.29%
2022	368.21 Million CNY	134.75%
2021	156.85 Million CNY	-44.45%
2020	282.36 Million CNY	2.91%
2019	274.39 Million CNY	34.16%
2018	204.52 Million CNY	11.72%
2017	183.06 Million CNY	1.58%
2016	180.2 Million CNY	21.71%
2015	148.06 Million CNY	5.61%
2014	140.2 Million CNY	1.11%
2013	138.66 Million CNY	0.0%

Year	Operating Expenses	Operating Expenses Growth
2024 Q2	128.16 Million CNY	0.0%
2023 FY	345.06 Million CNY	-6.29%
2023 Q2	192.44 Million CNY	4.98%
2022 Q2	184.89 Million CNY	-0.31%
2022 Q4	183.31 Million CNY	-0.85%
2022 FY	368.21 Million CNY	134.75%
2021 Q2	28.62 Million CNY	-82.3%
2021 FY	156.85 Million CNY	-44.45%
2021 Q4	185.47 Million CNY	547.99%
2020 Q4	161.69 Million CNY	34.0%
2020 Q2	120.67 Million CNY	-21.43%
2020 FY	282.36 Million CNY	2.91%
2019 Q2	120.81 Million CNY	6.73%
2019 FY	274.39 Million CNY	34.16%
2019 Q4	153.57 Million CNY	27.12%
2018 Q2	91.33 Million CNY	-16.17%
2018 Q4	113.19 Million CNY	23.94%
2018 FY	204.52 Million CNY	11.72%
2017 FY	183.06 Million CNY	1.58%
2017 Q4	108.95 Million CNY	47.02%
2017 Q2	74.1 Million CNY	-19.62%
2016 FY	180.2 Million CNY	21.71%
2016 Q2	88.01 Million CNY	9.75%
2016 Q4	92.19 Million CNY	4.76%
2015 FY	148.06 Million CNY	5.61%
2015 Q4	80.18 Million CNY	18.13%
2015 Q2	67.88 Million CNY	-2.93%
2014 FY	140.2 Million CNY	1.11%
2014 Q4	69.92 Million CNY	-0.5%
2014 Q2	70.28 Million CNY	-8.69%
2013 Q2	61.69 Million CNY	72.91%
2013 Q4	76.97 Million CNY	24.76%
2013 FY	138.66 Million CNY	0.0%
2012 Q4	35.68 Million CNY	0.0%

Peer Operating Expenses Comparison of Austar Lifesciences Limited

Name	Operating Expenses	Operating Expenses Difference
Vincent Medical Holdings Limited	174.6 Million HKD	-109.639%